Cloxacillin sodium monohydrate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

氯唑西林钠 (Cloxacap) 是氯唑西林的钠盐，是一种耐青霉素酶、耐酸的半合成青霉素。

Cloxacillin sodium (Cloxacap) is a sodium salt of cloxacillin that is a penicillinase-resistant, acid resistant, semi-synthetic penicillin. Cloxacillin sodium exerts a bactericidal action against susceptible microorganisms during the stage of active multiplication. Cloxacillin sodium acts through the inhibition of biosynthesis of cell wall mucopeptides.(In Vitro):Cloxacillin sodium monohydrate (0-2048 μg/mL; 20-24 h) shows good antibacterial activity for S. aureus 8325-4 and DU1090 with MIC values both of 0.125 μg/mL.Cloxacillin sodium monohydrate (0.015625 μg/mL; 6 h) inhibits the hemolytic activity of Hlα in vitro, and this inhibition is not only more pronounced when combined with TZ and TZ, but also suppresses the inflammatory response by inhibiting the activation of MAPKs, NF-кB and NLRP3-related proteins.(In Vivo):Cloxacillin sodium monohydrate (1.6125 mg/kg; s.c.; 12-h intervals for 72 h) protects mice from S. aureus peritonitis in vivo when combines with Thioridazine and Tetracycline.Cloxacillin sodium monohydrate (7.5 mg/per; i.p.; twice daily from day 3 for 3 days) develops less severe synovitis and reduces bone erosions when combines with anti-IL-15 antibodies.

Cloxacillin sodium monohydrate (0-2048 μg/mL; 20-24 h) shows good antibacterial activity for S. aureus 8325-4 and DU1090 with MIC values both of 0.125 μg/mL.Cloxacillin sodium monohydrate (0.015625 μg/mL; 6 h) inhibits the hemolytic activity of Hlα in vitro, and this inhibition is not only more pronounced when combined with TZ and TZ, but also suppresses the inflammatory response by inhibiting the activation of MAPKs, NF-кB and NLRP3-related proteins. Cell Viability Assay Cell Line:S. aureus 8325-4, S. aureus DU1090 (an Hlα-deleted strain)Concentration:0-2048 μg/mL Incubation Time:20-24 h Result:Inhibited S. aureus 8325-4 and DU1090 with MIC values both of 0.125 μg/mL.

Cloxacillin sodium monohydrate (1.6125 mg/kg; s.c.; 12-h intervals for 72 h) protects mice from S. aureus peritonitis in vivo when combines with Thioridazine and Tetracycline.Cloxacillin sodium monohydrate (7.5 mg/per; i.p.; twice daily from day 3 for 3 days) develops less severe synovitis and reduces bone erosions when combines with anti-IL-15 antibodies. Animal Model:Female BALB/c mice (6-week-old; peritonitis model).Dosage:1.6125 mg/kg (combines with TC (3.125 mg/kg) and TZ (25 mg/kg)) Administration:Subcutaneous injection; 12-h intervals for 72 h.Result:Reduced the degree of inflammatory cell infiltration in the mouse lung tissue and alveolar structures tended to be normal.Significantly reduced the pathological changes in spleen and liver tissue, as well as decreased the CFU counts of S. aureus in the peritoneal cavity.Animal Model:Female wildtype C57BL/6 mice (8-week-old; systemic S. aureus-induced arthritis model)Dosage:7.5 mg/per (combines with 25 μg/per anti-IL-15 antibodies) Administration:Intraperitoneal injection; twice daily from day 3 (after bacterial inoculation) and stopped at day 6.Result:Showed activities of reducing severe synovitis and bone erosions when combined with anti-IL-15 antibodies.

——

Others

Other Targets

Others

Infection

——

7081-44-9

475.88

C19H17ClN3NaO5S·H2O

>98% (HPLC)

Ethanol: 25 mg/mL (52.53 mM); Water: 55 mg/mL (115.57 mM); DMSO: 55 mg/mL (115.57 mM)

CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[Na+]

——

(-20℃)

With Ice Pack

≥ 2 years